comparemela.com

Latest Breaking News On - Phase three trial - Page 12 : comparemela.com

Transcripts for MSNBC Stephanie Ruhle Reports 20210924 13:22:00

30. i think what people what some people are worried about with what dr. walensky has done is she basically said, no, i think it s okay to give it to the person greater than 18 even if they are not high risk. the problem is when pfizer did its phase three trial, two-dose trial it was a 40,000 person trial. when they did these phase three trial for the three doze vaccine it was a 306 person trial. i think that s why that all came down that way. heidi, you are at a vaccination center so obviously the people there who are getting their booster, they re happy about it, otherwise they wouldn t be there. give us a general sense of the amount of people they are expecting, the enthusiasm. if people sound skeptical at all, i mean, think back to the spring when you and i were talking our biggest worry was people cutting in line because we desperately were trying to

People
Person
Risk
Problem
Pfizer
Rochelle-walensky
Dr
18
30
Phase-three-trial
Vaccine
Person-trial

Transcripts for MSNBC Hallie Jackson Reports 20210923 19:12:00

then go to people who are at high risk of severe disease and then go to people who work in places like hospitals, grocery stores, pharmacies. a high risk of transmission of the virus. we ll see. they may choose to test the water with one foot at a time. if you think about this for a second. when pfizer did its trial, its phase three trial looking for people over 65 years of age. 20,000 got the placebo. that was a big safety and efficacy platform to stand on. when submitting this vaccine a third dose, basically 306 people that got a third dose. so the safety profile is not quite as robust as you d like, as was for the original. may choose to go more slowly. we ll see. and why did the panel recommend thisbooster and do up see it approved for the wider

People
Risk
Hospitals
Disease
Places
Grocery-stores
Transmission
Pharmacies
Virus
Water
One
Pfizer

Transcripts for MSNBC Craig Melvin Reports 20210818 15:30:00

that higher levels of anti-body are associated with higher levels after vaccine efficacy. this is referred to as an immune correlate. this is a paper recently published. it shows a model of vaccine efficacy based on the phase three trial showed that four weeks after the second dose that what you have is a neutralization of one to 100 that goes up from the vertical red line. that gives you an efficacy of 91%. if you look at the dark black line going from left to right, as you go further up you get a higher degree of efficacy. so the higher the neutralization, the higher degree of efficacy of the vaccine in this model.

Levels
Paper
Vaccine-efficacy
Anti-body
Immune
Dose
Model
Phase-three-trial
Four
Three
Neutralization
Line

Transcripts for MSNBC All In With Chris Hayes 20210203 08:50:30

Transcripts for MSNBC All In With Chris Hayes 20210203 08:50:30
archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.

Don-t
Taxes
Changes
Chances
Jackson-hewitt
100
Phase-three-trial
Folks
Scale
Postage
Post-office
Services

Transcripts for CNN Anderson Cooper 360 20210129 05:37:15

Transcripts for CNN Anderson Cooper 360 20210129 05:37:15
archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.

Congressman-mccarthy
One
Senate
Example
Impeachment-trial
Democrat
Teams
Prosecution
Defense
Phase-three-trial
Votes
Professor-tribe
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.